Facebook Twitter Linkedin

Membership
About
Advocacy
Resources
Member Log In

Advocacy

compliance1-150x150

position_statements.1_thumb

Position Statements

regulatory1-150x150

Regulatory/Legislative

Leave a Comment Cancel Reply

You must be logged in to post a comment.

Upcoming Events

2020 Membership Meeting

March 6

View All Events

NEWS

AAHP 2019: Reawakening the Regulatory and Retail Dialog December 10, 2019 By Mark Land, AAHP President This year marks the fifth year in a cycle of regulatory review of homeopathic drug product labeling, safety, and quality. AAHP has been there for the industry as an advocate and representative over the entire duration. In 2019 AAHP provided direction and regulatory thought-leadership within the homeopathic community, met with FDA’s ...
Trump Nominates New FDA Commissioner November 12, 2019 Senate Hearing Set for Nov. 20 By Pete Evich, AAHP Govt. Relations On Nov. 1, President Trump nominated Stephen Hahn, chief medical executive of the MD Anderson Cancer Center in Houston, to be the next U.S. Food and Drug Administration (FDA) commissioner. If confirmed by the Senate, a process that could take several months, Hahn will take the ...
Why It’s Crucial to Monitor FDA Guidances September 11, 2019 By Mark Land, AAHP President It can take several years for manufacturers to implement new guidelines from the Food and Drug Administration (FDA)—and that means they could be at risk in the meantime. However, manufacturers can “get ahead of the game” by monitoring FDA’s guidance development agenda. FDA’s authority to regulate stems from the Federal Food, Drug, ...

Newsletter SignUp

Name
First Last
Email
CAPTCHA